CVI Holdings’s Intelligent Medicine Acquisition Corp. Class A Common Stock IQMD Stock Holding History

CVI Holdings’s Portfolio IQMD Stock Details IQMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-112,453	Closed	-$1.16M	–	561
2022 Q4	$1.16M	Sell	112,453 -7,432	-6%	-$75.5K	0.15%	176
2022 Q3	$1.21M	Hold	119,885	–	–	0.09%	304
2022 Q2	$1.2M	Hold	119,885	–	–	0.09%	327
2022 Q1	$1.2M	Buy	+119,885	New	+$1.19M	0.08%	357

Other funds holding IQMD

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return

Walleye Trading New York $60B AUM 42.19% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Allworth Financial Folsom, California $24.7B AUM 15.55% 1-Year Est. Return

CVI Holdings's IQMD Position: Q1 2023 in Review

CVI Holdings sold out of Intelligent Medicine Acquisition Corp. Class A Common Stock (IQMD) in Q1 2023, closing a stake of 112,453 shares — an estimated $1.16M sold.

CVI Holdings first reported a position in IQMD in Q1 2022 and held it in 4 quarters. The position peaked at $1.21M in Q3 2022. 8 funds tracked by Wall St. Rank hold IQMD as of Q1 2023.

CVI Holdings reported no remaining Intelligent Medicine Acquisition Corp. Class A Common Stock position as of Q1 2023 after selling out during the quarter.
CVI Holdings sold 112,453 Intelligent Medicine Acquisition Corp. Class A Common Stock shares in Q1 2023, an estimated $1.16M.
CVI Holdings first reported a position in Intelligent Medicine Acquisition Corp. Class A Common Stock in Q1 2022 and held it in 4 quarters.
CVI Holdings's Intelligent Medicine Acquisition Corp. Class A Common Stock position peaked at $1.21M in Q3 2022.
8 funds tracked by Wall St. Rank held Intelligent Medicine Acquisition Corp. Class A Common Stock as of Q1 2023.

Based on CVI Holdings's 13F filing for Q1 2023, filed 16 May 2023.